MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Kyrgyzstan is among the 27 countries with the highest burdens of MDR-TB in the world.

More >

Ukrainian prisons are a hotbed for the disease, with prevalence rates more than ten times higher than in the rest of society.

More >

The first new drug approved to treat tuberculosis (TB) since 1963 could result in shorter treatment with less side effects and the opportunity to treat more people. For people with drug-resistant TB, it could present a new lifeline.

More >

After years of conflict, a large number of tuberculosis (TB) cases are now being diagnosed in Chechnya. Half are drug-resistant cases. To help ensure that patients adhere to treatment, Doctors Without Borders/Médecins Sans Frontières (MSF) has set up a counseling program which is an integral part of the treatment.

More >

Forty-eight-year-old Mary Marizani recently became the first MSF patient in Zimbabwe to conquer multidrug-resistant tuberculosis.

More >

Two patients being treated by MSF for tuberculosis in Tajikistan tell their stories.

More >
Gifts to MSF in memory JustGiving button

MSF is adopting new strategies to fight drug-resistant tuberculosis among children and families in Tajikistan.

More >

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

More >

Multidrug-resistant tuberculosis patient and TB&ME blogger Athong talks from India about the stigma he faces living with the disease. Read Athong's TB&ME blog here.

More >

Phumeza is an XDR-TB patient and a blogger for the TB&ME project. This is her first video blog from her home at a TB patient facility in South Africa. Read Phumeza's TB&ME blog here. 

More >

Pages